No 1D chart data available
Bid | 69.5 |
Market Cap | 40.71B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 1.93 |
PE Ratio (ttm) | 36.67 |
Forward PE | n/a |
Analyst | n/a |
Ask | 72.18 |
Volume | 1,711,009 |
Avg. Volume (20D) | 3,197,965 |
Open | 71.71 |
Previous Close | 72.18 |
Day's Range | 69.88 - 71.69 |
52-Week Range | 58.10 - 84.15 |
Beta | undefined |
Next Earnings Release
is scheduled to release its earnings on Apr 24, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription

3 months ago · accessnewswire.com
Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesSEATTLE, WA / ACCESS Newswire / April 21, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology ...

3 months ago · businesswire.com
Sleep Number Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation (Nasdaq: SNBR) today announced that it granted equity awards on April 15, 2025, as a material inducement to the employment of the company's newly...